The Clinical Evaluation of Two Daily Disposable Contact Lenses
- Conditions
- Myopia
- Interventions
- Device: etafilcon ADevice: omafilcon A
- Registration Number
- NCT00762996
- Lead Sponsor
- Johnson & Johnson Vision Care, Inc.
- Brief Summary
The objective of this study is to evaluate the clinical performance of two daily disposable contact lenses.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 65
- They are of legal age (18 years) and capacity to volunteer.
- They understand their rights as a research subject and are willing to sign a Statement of Informed Consent.
- They are willing and able to follow the protocol.
- They would be expected to attain at least 6.9 (20/30) in each eye with the study lenses.
- They are able to wear contact lenses which have a back vertex power of -1.00 to -6.00DS.
- They have a maximum of 1.00D of refractive astigmatism (i.e. < 1.00 DC).
- They have worn soft contact lenses within six months of starting the study.
- They have an ocular disorder which would normally contra-indicate contact lens wear.
- They have a systemic disorder which would normally contra-indicate contact lens wear.
- They are using any topical medication such as eye drops or ointment.
- They are aphakic.
- They have had corneal refractive surgery.
- They have any corneal distortion resulting from previous hard or rigid lens wear or has keratoconus.
- They are pregnant or lactating.
- They have grade 2 or greater of any of the following ocular surface signs: corneal edema, corneal vascularization, corneal staining, tarsal conjunctival changes or any other abnormality which would normally contraindicate contact lens wear.
- They have any infectious disease (e.g., hepatitis) or any immunosuppressive disease (e.g., HIV).
- They have diabetes.
- They are currently taking part in any other clinical study or research.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description etafilcon A/omafilcon A etafilcon A Period 1: etafilcon A, Period 2: omafilcon A etafilcon A/omafilcon A omafilcon A Period 1: etafilcon A, Period 2: omafilcon A omafilcon A/etafilcon A etafilcon A Period 1: omafilcon A, Period 2: etafilcon A omafilcon A/omafilcon A omafilcon A Period 1: omafilcon A, Period 2: omafilcon A etafilcon A/etafilcon A etafilcon A Period 1: etafilcon A, Period 2: etafilcon A omafilcon A/etafilcon A omafilcon A Period 1: omafilcon A, Period 2: etafilcon A
- Primary Outcome Measures
Name Time Method Distance Visual Acuity 1 week logarithm of the minimum angle of resolution (logMar) ideal is 0.0 and represents 20/20 Snellen acuity. logMar values \> 0.00 indicate vision poorer than the ideal and values \<0.00 indicate vision greater than the ideal.
- Secondary Outcome Measures
Name Time Method Lens Comfort 1 week A weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale: 1=most negative response to 5=most positive was used to derive comfort outcomes. The analysis shows the difference in outcome between the test and control.\>0 = comfortable, \<0 = uncomfortable
Trial Locations
- Locations (1)
Eurolens Research
🇬🇧Manchester, United Kingdom